Intellectual Property

  • April 16, 2025

    NC Hospital Beats Weight Loss Clinic's Trademark Suit

    A North Carolina federal judge tossed a Tar Heel State weight loss clinic's trademark infringement suit, calling the clinic's mark "relatively weak" and finding it has "very little similarity" to the purportedly infringing mark used by the hospital and healthcare provider it sued.

  • April 16, 2025

    Jack Nicklaus Granted $1M In Damages After NIL Win

    Jack Nicklaus was granted $1 million Wednesday by a New York state court judge for damages incurred as a result of a preliminary injunction that prevented the golf legend from signing new commercial deals during now-dismissed litigation over the use of his name, image and likeness.

  • April 15, 2025

    Astellas Bladder Drug Patent Survives Following Bench Trial

    A Delaware federal judge on Tuesday held that generic-drug makers Lupin and Zydus Pharmaceuticals haven't shown "by clear and convincing evidence" that an Astellas Pharma patent covering the bladder medication Myrbetriq is invalid.

  • April 15, 2025

    Biogen, Genentech Head To June Trial Over MS Drug Royalties

    A California federal judge on Tuesday denied Biogen's bid for summary judgment in a high-stakes contract fight with Roche Holding AG subsidiary Genentech over patent royalties on multiple sclerosis drug sales, saying during a hearing that there's a material dispute over the contract's language and the case will be tried in June.

  • April 15, 2025

    X Corp. Should Pay $632M For Stealing Video IP, Jury Hears

    X Corp. systematically copied a startup's video sharing technology while stringing it along with promises of a partnership, VidStream LLC told a Dallas jury during closing arguments Tuesday in a $632 million intellectual property suit that has spanned nearly a decade.

  • April 15, 2025

    Westlaw Rival Urges 3rd Circ. Intervention In AI Fair Use Case

    Tech startup ROSS Intelligence has urged the Third Circuit to allow a quick appeal focusing on two key questions from a lower court decision concluding it infringed copyrighted material from Thomson Reuters' Westlaw platform to create an artificial intelligence-backed competing legal research tool. 

  • April 15, 2025

    Meta Used Pirated Data To Evaluate Licensing, Authors Say

    A group of bestselling authors accusing Meta Platforms of copyright infringement allege the tech company downloaded databases with millions of pirated books not just to train its large language models, called Llama, but also to see whether it could develop them without licensing content, according to a newly unredacted summary judgment motion.

  • April 15, 2025

    AI Artist Hires Atty Challenging Human-Only Copyright Rule

    A Colorado artist suing the U.S. Copyright Office over its refusal to register a work created on an artificial intelligence platform has a new attorney — the same lawyer who is representing a computer scientist challenging the government agency's position that only human authors qualify for copyright protection.

  • April 15, 2025

    Fed. Circ. Won't Rethink Prior Art Decision In Samsung Row

    The Federal Circuit shot down tech developer Lynk Labs Inc.'s bid for the full appellate court to review when a patent application counts as prior art, cementing a win for patent challenger Samsung in the case.

  • April 15, 2025

    3 USPTO Updates You Should Know About

    Probationary patent examiners and trademark examining attorneys within 50 miles of the U.S. Patent and Trademark Office's Virginia offices will have to start working from those facilities, one of three recent changes at the agency. Here's what you need to know.

  • April 15, 2025

    Microsoft, Okta Say Their Password Products Don't Infringe IP

    Microsoft Corp. and information technology service management company Okta Inc. asked a California federal judge Monday for declarations that their password-generating products don't infringe a San Francisco company's patent covering a method for issuing time-based, one-time passwords.

  • April 15, 2025

    Intel Says Withdrawal Of Fintiv Memo Doesn't Help VLSI Case

    Intel says the U.S. Patent and Trademark Office's recent withdrawal of guidance on its discretionary-denial policy doesn't mean the Federal Circuit should revive a VLSI Technology chip patent, hitting back at VLSI's argument to the contrary.

  • April 15, 2025

    Some GoPro Cameras Infringe Patent, Calif. Judge Rules

    A California federal judge has ruled that several GoPro cameras infringe a patent revived by the Federal Circuit last year but said a jury needs to hear the issue of whether other products infringe.

  • April 15, 2025

    Fed. Circ. Won't Revive Stryker Unit's Antiseptic Patents

    The Patent Trial and Appeal Board properly invalidated claims in two Sage Products LLC patents for sterilizing antiseptics, the Federal Circuit affirmed Tuesday.

  • April 15, 2025

    9th Circ. Backs $272M Verdict For Monster In Bang Ad Case

    The Ninth Circuit on Tuesday affirmed a $272 million verdict for Monster Energy Co. in a false advertising case against defunct Vital Pharmaceuticals Inc. and its former CEO, rejecting a series of challenges to rulings that narrowed the evidence at trial.

  • April 15, 2025

    Judge Again Denies Arbitration In Chicago Cubs License Spat

    A Chicago federal court will not reconsider dismissing a lawsuit that accuses a rooftop owner of selling tickets to Chicago Cubs games and other events without a license, ruling it got it right the first time.

  • April 15, 2025

    Hogan Lovells IP Pro Jumps To Venable In San Francisco

    Venable LLP is expanding its intellectual property team, announcing Tuesday it is bringing in a Hogan Lovells IP litigator as a partner in its San Francisco office.

  • April 15, 2025

    Holland & Knight Litigator Heads To Florida Boutique

    Florida-based litigation and appellate boutique Lawson Huck Gonzalez PLLC has added a former Holland & Knight LLP partner to its Miami-area office, bringing on an attorney who has handled high-stakes litigation and appellate matters for clients in private practice.

  • April 15, 2025

    Roster Limits Stay In Revisions To NCAA's NIL Settlement

    In court-ordered revisions to their $2.78 billion antitrust class action settlement, the NCAA and the athlete class added greater protections for athletes entering college throughout the deal's 10-year span, but refused to budge on roster limits opposed by several objectors.

  • April 14, 2025

    Backers Of Meta, Authors Clash Over Fair Use In AI Training

    The conflict between bestselling authors and Meta Platforms Inc. over the use of their works for training artificial intelligence software has drawn numerous amicus briefs that underscore the stakes involved, with warnings of devastating consequences for the future of AI development or the rights of copyright owners depending on how the court rules.

  • April 14, 2025

    Musk Supports Deleting IP Law, Attorneys Say Let's Not

    Elon Musk's endorsement of a terse social media post from tech executive Jack Dorsey saying "delete all IP law" drew scorn from the intellectual property community and was followed by posts from U.S. Patent and Trademark Office acting Director Coke Morgan Stewart extolling the virtues of trademark, patent and copyright protections.

  • April 14, 2025

    Fed. Circ. Hears Teva Challenge To J&J Schizophrenia Drug

    A Federal Circuit panel on Monday grappled with how to determine whether a dosage patent on Johnson & Johnson's blockbuster schizophrenia drug Invega Sustenna is invalid as obvious, questioning attorneys for the company and generics maker Teva about the proper analysis.

  • April 14, 2025

    Groupon Urges Full Fed. Circ. To Undo Panel's IP Suit Revival

    Groupon Inc. is pushing the full Federal Circuit to intervene after a panel allowed Kroy IP Holdings to proceed with a suit accusing it of infringing unchallenged claims of partly invalidated patents.

  • April 14, 2025

    Ozempic Pretender On Sale In Conn., Novo Nordisk Says

    A Connecticut company is selling compounded drugs that purport to contain semaglutide, the active ingredient in Novo Nordisk medications including Ozempic, and improperly implying that the products are approved by the U.S. Food and Drug Administration, according to a lawsuit that alleges violations of state and federal law.

  • April 14, 2025

    Fed. Circ. Won't Revive Bid To Cancel Saints' Fleur-De-Lis TM

    The Federal Circuit on Monday threw out an appeal by a man claiming to be the descendant of French royalty who unsuccessfully tried to have the Trademark Trial and Appeal Board cancel the New Orleans Saints football team's fleur-de-lis design mark.

Expert Analysis

  • How To Accelerate Your Post-Attorney Career Transition

    Author Photo

    Professionals seeking to transition to nonattorney careers may encounter skepticism as nontraditional candidates, but there are opportunities for thought leadership and to leverage speaking and writing to accelerate a post-attorney career transition, say Janet Falk at Falk Communications and Evgeny Efremkin at Toronto Metropolitan University.

  • 5 Key Licensing Considerations For AI Innovations

    Author Photo

    As businesses increasingly integrate artificial intelligence technology into their operations, they must prepare to address complex intellectual property challenges and questions surrounding licensing AI-based innovations, which require careful consideration of ownership, usage rights and regulatory compliance, says Lestin Kenton at Sterne Kessler.

  • A Higher Bar For Expert Witnesses In Drug Patent Litigation

    Author Photo

    With recent decisions emphasizing courts' growing insistence on robust methodologies in pharmaceutical patent disputes, litigators must be strategic in how they utilize expert testimony and adapt to venue-specific expectations, says Jeremy Scholem at WIT Legal.

  • Series

    Law School's Missed Lessons: Be An Indispensable Associate

    Author Photo

    While law school teaches you to research, write and think critically, it often overlooks the professional skills you will need to make yourself an essential team player when transitioning from a summer to full-time associate, say attorneys at Stinson.

  • Protecting Brand Identity In An AI-Driven Marketplace

    Author Photo

    A lawsuit recently filed in New York federal court marks a critical moment in the intersection of artificial intelligence and trademark law, underscoring the importance of — and challenges surrounding — IP owners' ability to protect their brands as AI-generated content continues to grow, says Wendy Heilbut at Heilbut LLC.

  • Series

    Birding Makes Me A Better Lawyer

    Author Photo

    Observing and documenting birds in their natural habitats fosters patience, sharpens observational skills and provides moments of pure wonder — qualities that foster personal growth and enrich my legal career, says Allison Raley at Arnall Golden.

  • Justices May Clarify What IP Competitors In Litigation Can Say

    Author Photo

    If the U.S. Supreme Court agrees to weigh in on Atturo Tire v. Toyo Tire, it may be able to provide guidance on the murky questions surrounding what companies enforcing their intellectual property against competitors are allowed to say in public, say attorneys at Ballard Spahr.

  • How To Ensure Confidentiality When Using AI In Discovery

    Author Photo

    In light of a recent case in the Southern District of New York involving the dissemination of AI-generated content containing confidential information, there are steps that law firms and lawyers should take to protect client and third-party data during litigation, say attorneys at Steptoe.

  • An Update On IPR Issue Preclusion In District Court Litigation

    Author Photo

    Two recent Federal Circuit rulings have resolved a district court split regarding issue preclusion based on Patent Trial and Appeal Board outcomes, potentially counseling petitioners in favor of challenging not only all the claims of an asserted patent, but also related patents that have not yet been raised in district court, say attorneys at Alston & Bird.

  • Series

    Adapting To Private Practice: From DOJ Leadership To BigLaw

    Author Photo

    The move from government service to private practice can feel like changing one’s identity, but as someone who has left the U.S. Department of Justice twice, I’ve learned that a successful transition requires patience, effort and the realization that the rewards of practicing law don’t come from one particular position, says Richard Donoghue at Pillsbury.

  • In-House Expert Testimony Is Tricky, But Worth Considering

    Author Photo

    Litigation counsel often reject the notion of designating in-house personnel to provide expert opinion testimony at trial, but dismissing them outright can result in a significant missed opportunity, say David Ben-Meir at Ben-Meir Law and Martin Pitha at Lillis Pitha.

  • Fed. Circ. Ruling Reaffirms Listing Elements Separately Is Key

    Author Photo

    The Federal Circuit's decision last month in Regeneron v. Mylan reaffirms a critical principle in patent law: When a claim lists elements separately, the clear implication is that they are distinct elements, say attorneys at Taft.

  • Tracking Changes To AI Evidence Under Federal Rules

    Author Photo

    As the first quarter of 2025 draws to a close, important changes to the Federal Rules of Evidence regarding the use of artificial intelligence in the courtroom are on the horizon, including how to handle evidence that is a product of machine learning, say attorneys at Debevoise.

  • Law Firm Executive Orders Create A Legal Ethics Minefield

    Author Photo

    Recent executive orders targeting BigLaw firms create ethical dilemmas — and raise the specter of civil or criminal liability — for the government attorneys tasked with implementing them and for the law firms that choose to make agreements with the administration, say attorneys at Buchalter.

  • Firms Must Embrace Alternative Billing Models Or Fall Behind

    Author Photo

    As artificial intelligence tools eliminate inefficiencies and the Big Four accounting firms enter the legal market, law firms that pivot from the entrenched billable hour model to outcomes-based pricing will see a distinct competitive advantage, says attorney William Brewer.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!